Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
May 07 2020 - 6:05AM
Edgar (US Regulatory)
Filed by BioPharmX Corporation pursuant to
Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-6
under the Securities Exchange Act of 1934
Subject Company: BioPharmX Corporation (SEC
File No. 001-37411)
Commission File No. for the Related Registration
Statement: 333-236526
900 E. Hamilton Ave., Suite
100
Campbell, CA 95008
(650) 889-5020
www.BioPharmX.com
Dear BioPharmX Shareholder:
YOUR
PARTICIPATION IS IMPORTANT – PLEASE VOTE TODAY!
According to our
latest records, your proxy vote relating to the BioPharmX Special Meeting of Stockholders has not yet been received.
|
You
have until May 12 2020, at 11:59 p.m. EST to vote your shares.
PLEASE VOTE TODAY using
the link that accompanied this letter.
|
|
BioPharmX appreciates your investment
and asks for your vote on the following items:
Item
1
|
APPROVE
ISSUANCE OF BIOPHARMX'S COMMON STOCK TO TIMBER'S MEMBERS
|
Vote
FOR
|
Item
2
|
APPROVE
A REVERSE STOCK SPLIT OF BIOPHARMX'S COMMON STOCK
|
Vote
FOR
|
Item
3
|
APPROVE
AMENDMENT FOR CHANGE IN CORPORATE NAME
|
Vote
FOR
|
Item
4
|
APPROVE
TIMBER PHARMACEUTICALS 2020 OMNIBUS EQUITY INCENTIVE PLAN
|
Vote
FOR
|
Item
5
|
APPROVE
ISSUANCE OF STOCK UPON EXERCISE OF INVESTOR WARRANT
|
Vote
FOR
|
Item
6
|
ADJOURN
THE MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES
|
Vote
FOR
|
Item
7
|
TRANSACT
OTHER BUSINESS AS MAY COME BEFORE THE SPECIAL MEETING
|
Vote
FOR
|
If you have any questions please contact our proxy solicitor
Alliance Advisors toll free at: (833) 782-7191.
If you have recently mailed your proxy card or cast your vote
by phone or internet, please accept our thanks and disregard this request.
Sincerely,
Steven M. Bosacki
Chief Executive Officer
BioPharmX (AMEX:BPMX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioPharmX (AMEX:BPMX)
Historical Stock Chart
From Apr 2023 to Apr 2024